These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 18383859)

  • 41. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
    Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
    J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitory effects of a gradient static magnetic field on normal angiogenesis.
    Wang Z; Yang P; Xu H; Qian A; Hu L; Shang P
    Bioelectromagnetics; 2009 Sep; 30(6):446-53. PubMed ID: 19405043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Down-regulation of vascular endothelial growth factor receptor 2 is a major molecular determinant of proteasome inhibitor-mediated antiangiogenic action in endothelial cells.
    Meissner M; Reichenbach G; Stein M; Hrgovic I; Kaufmann R; Gille J
    Cancer Res; 2009 Mar; 69(5):1976-84. PubMed ID: 19223539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extracellular HSP70 blocks CD40L-induced apoptosis and tubular formation in endothelial cells.
    Futagami S; Hiratsuka T; Shindo T; Hamamoto T; Horie A; Ueki N; Kusunoki M; Gudis K; Miyake K; Tsukui T; Sakamoto C
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S222-8. PubMed ID: 19120902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.
    Lu J; Chong CR; Hu X; Liu JO
    J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RK-95113, a new angiogenesis inhibitor produced by Aspergillus fumigatus.
    Asami Y; Kakeya H; Okada G; Toi M; Osada H
    J Antibiot (Tokyo); 2006 Nov; 59(11):724-8. PubMed ID: 17256472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of lipoxin A(4) on CoCl(2)-induced angiogenesis and its possible mechanisms in human umbilical vein endothelial cells.
    Liu S; Wu P; Ye D; Huang Y; Zhou X; Li Y; Cai L
    Pharmacology; 2009; 84(1):17-23. PubMed ID: 19478549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Juice of eclipta prostrata inhibits cell migration in vitro and exhibits anti-angiogenic activity in vivo.
    Lirdprapamongkol K; Kramb JP; Chokchaichamnankit D; Srisomsap C; Surarit R; Sila-Asna M; Bunyaratvej A; Dannhardt G; Svasti J
    In Vivo; 2008; 22(3):363-8. PubMed ID: 18610749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite.
    Touil YS; Auzeil N; Boulinguez F; Saighi H; Regazzetti A; Scherman D; Chabot GG
    Biochem Pharmacol; 2011 Dec; 82(11):1731-9. PubMed ID: 21840301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.
    Kong D; Okamura M; Yoshimi H; Yamori T
    Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds.
    Fuchs S; Ghanaati S; Orth C; Barbeck M; Kolbe M; Hofmann A; Eblenkamp M; Gomes M; Reis RL; Kirkpatrick CJ
    Biomaterials; 2009 Feb; 30(4):526-34. PubMed ID: 18977026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mathematical modeling of the capillary-like pattern generated by adrenomedullin-treated human vascular endothelial cells in vitro.
    Guidolin D; Albertin G; Sorato E; Oselladore B; Mascarin A; Ribatti D
    Dev Dyn; 2009 Aug; 238(8):1951-63. PubMed ID: 19618467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and antiangiogenic activity of new silybin galloyl esters.
    Gažák R; Valentová K; Fuksová K; Marhol P; Kuzma M; Medina MÁ; Oborná I; Ulrichová J; Křen V
    J Med Chem; 2011 Oct; 54(20):7397-407. PubMed ID: 21928794
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The anti-angiogenic effects of 1-furan-2-yl-3-pyridin-2-yl-propenone are mediated through the suppression of both VEGF production and VEGF-induced signaling.
    Park BC; Park SY; Lee JS; Mousa SA; Kim JT; Kwak MK; Kang KW; Lee ES; Choi HG; Yong CS; Kim JA
    Vascul Pharmacol; 2009; 50(3-4):123-31. PubMed ID: 19068239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor.
    Chen L; Lu Y; Wu JM; Xu B; Zhang LJ; Gao M; Zheng SZ; Wang AY; Zhang CB; Zhang WW; Lei N
    Biochem Biophys Res Commun; 2009 Aug; 386(2):374-9. PubMed ID: 19523924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 13 cis-retinoic acid regulates cytokine production and inhibits angiogenesis by disrupting endothelial cell migration and tube formation.
    Guruvayoorappan C; Kuttan G
    J Exp Ther Oncol; 2008; 7(3):173-82. PubMed ID: 19066126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial activity of lupulone against Clostridium perfringens in the chicken intestinal tract jejunum and caecum.
    Siragusa GR; Haas GJ; Matthews PD; Smith RJ; Buhr RJ; Dale NM; Wise MG
    J Antimicrob Chemother; 2008 Apr; 61(4):853-8. PubMed ID: 18276602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo matrigel migration and angiogenesis assay.
    Malinda KM
    Methods Mol Biol; 2009; 467():287-94. PubMed ID: 19301678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis.
    Sakai T; Balasubramanian K; Maiti S; Halder JB; Schroit AJ
    Am J Pathol; 2007 Nov; 171(5):1659-69. PubMed ID: 17872974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-angiogenic properties of plaunotol.
    Kawai K; Tsuno NH; Kitayama J; Okaji Y; Yazawa K; Asakage M; Yamashita H; Watanabe T; Takahashi K; Nagawa H
    Anticancer Drugs; 2005 Apr; 16(4):401-7. PubMed ID: 15746576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.